← Back to Search

Procedure

Sentinel Node Biopsy for Uterine Cancer

N/A
Waitlist Available
Led By Waldo G Jimenez, MD MSc
Research Sponsored by Hamilton Health Sciences Corporation
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up measurement will be performed 2-4 hours after the cervical injection with technetium 99
Awards & highlights
No Placebo-Only Group

Summary

The purpose of this study is to determine if there is a difference between the lymphatic drainage of the cervix and corpus of the uterus after injecting a radiocolloid in the cervix and blue dye in the corpus of the uterus and to investigate the identification rate of sentinel nodes using this technique in patients with cancer of the uterus.

Eligible Conditions
  • Uterine Cancer
  • Sentinel Lymph Node Biopsy

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~measurement for each participant will be performed between 2-4 hours after injecting technetium 99 in the cervix
This trial's timeline: 3 weeks for screening, Varies for treatment, and measurement for each participant will be performed between 2-4 hours after injecting technetium 99 in the cervix for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Location of Sentinel node
Secondary study objectives
Identification of metastatic lymph nodes by the sentinel node procedure

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

1Treatment groups
Experimental Treatment
Group I: Sentinel Node BiopsyExperimental Treatment1 Intervention
Each participant will have both measurements, the new diagnostic test (sentinel node biopsy) and the gold standard (complete lymphadenectomy)
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Sentinel Lymph Node Biopsy
2004
Completed Phase 3
~350

Find a Location

Who is running the clinical trial?

Hamilton Health Sciences CorporationLead Sponsor
377 Previous Clinical Trials
340,350 Total Patients Enrolled
Juravinski Cancer Centre FoundationOTHER
12 Previous Clinical Trials
1,903 Total Patients Enrolled
Waldo G Jimenez, MD MScPrincipal InvestigatorMcMaster University
~4 spots leftby Nov 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top